| Assessing synaptic density in Alzheimer disease with synaptic vesicle glycoprotein 2A positron emission tomographic imaging MK Chen, AP Mecca, M Naganawa, SJ Finnema, T Toyonaga, S Lin, ... JAMA neurology 75 (10), 1215-1224, 2018 | 361 | 2018 |
| In vivo measurement of widespread synaptic loss in Alzheimer's disease with SV2A PET AP Mecca, MK Chen, RS O'Dell, M Naganawa, T Toyonaga, TA Godek, ... Alzheimer's & Dementia 16 (7), 974-982, 2020 | 189 | 2020 |
| Synaptic changes in Parkinson disease assessed with in vivo imaging D Matuskey, S Tinaz, KC Wilcox, M Naganawa, T Toyonaga, M Dias, ... Annals of neurology 87 (3), 329-338, 2020 | 133 | 2020 |
| Assessment of a white matter reference region for 11C-UCB-J PET quantification S Rossano, T Toyonaga, SJ Finnema, M Naganawa, Y Lu, N Nabulsi, ... Journal of Cerebral Blood Flow & Metabolism 40 (9), 1890-1901, 2020 | 91 | 2020 |
| Association of Aβ deposition and regional synaptic density in early Alzheimer’s disease: a PET imaging study with [11C]UCB-J RS O’Dell, AP Mecca, MK Chen, M Naganawa, T Toyonaga, Y Lu, ... Alzheimer's Research & Therapy 13, 1-12, 2021 | 70 | 2021 |
| Synaptic density and cognitive performance in Alzheimer's disease: A PET imaging study with [11C]UCB‐J AP Mecca, RS O'Dell, ES Sharp, ER Banks, HH Bartlett, W Zhao, S Lipior, ... Alzheimer's & Dementia 18 (12), 2527-2536, 2022 | 68 | 2022 |
| Comparison of [11C]UCB-J and [18F]FDG PET in Alzheimer’s disease: A tracer kinetic modeling study MK Chen, AP Mecca, M Naganawa, JD Gallezot, T Toyonaga, J Mondal, ... Journal of Cerebral Blood Flow & Metabolism 41 (9), 2395-2409, 2021 | 65 | 2021 |
| In vivo synaptic density imaging with 11C-UCB-J detects treatment effects of saracatinib in a mouse model of Alzheimer disease T Toyonaga, LM Smith, SJ Finnema, JD Gallezot, M Naganawa, J Bini, ... Journal of Nuclear Medicine 60 (12), 1780-1786, 2019 | 65 | 2019 |
| In vivo evidence of lower synaptic vesicle density in schizophrenia R Radhakrishnan, PD Skosnik, M Ranganathan, M Naganawa, ... Molecular Psychiatry 26 (12), 7690-7698, 2021 | 60 | 2021 |
| Reduced synaptic vesicle protein 2A binding in temporal lobe epilepsy: A [11C]UCB‐J positron emission tomography study SJ Finnema, T Toyonaga, K Detyniecki, MK Chen, M Dias, Q Wang, ... Epilepsia 61 (10), 2183-2193, 2020 | 57 | 2020 |
| Hypoxic glucose metabolism in glioblastoma as a potential prognostic factor T Toyonaga, S Yamaguchi, K Hirata, K Kobayashi, O Manabe, ... European journal of nuclear medicine and molecular imaging 44, 611-619, 2017 | 53 | 2017 |
| Reversal of synapse loss in Alzheimer mouse models by targeting mGluR5 to prevent synaptic tagging by C1Q J Spurrier, LS Nicholson, XT Fang, AJ Stoner, T Toyonaga, D Holden, ... Science translational medicine 14 (647), eabi8593, 2022 | 44 | 2022 |
| Data-driven voluntary body motion detection and non-rigid event-by-event correction for static and dynamic PET Y Lu, JD Gallezot, M Naganawa, S Ren, K Fontaine, J Wu, JA Onofrey, ... Physics in Medicine & Biology 64 (6), 065002, 2019 | 42 | 2019 |
| Synthesis and Preclinical Evaluation of an 18F-Labeled Synaptic Vesicle Glycoprotein 2A PET Imaging Probe: [18F]SynVesT-2 Z Cai, S Li, W Zhang, R Pracitto, X Wu, E Baum, SJ Finnema, D Holden, ... ACS chemical neuroscience 11 (4), 592-603, 2020 | 39 | 2020 |
| Data-driven motion detection and event-by-event correction for brain PET: Comparison with Vicra Y Lu, M Naganawa, T Toyonaga, JD Gallezot, K Fontaine, S Ren, ... Journal of Nuclear Medicine 61 (9), 1397-1403, 2020 | 36 | 2020 |
| 18F-fluoromisonidazole positron emission tomography can predict pathological necrosis of brain tumors T Toyonaga, K Hirata, S Yamaguchi, KC Hatanaka, S Yuzawa, O Manabe, ... European journal of nuclear medicine and molecular imaging 43, 1469-1476, 2016 | 36 | 2016 |
| Imaging of synaptic density in neurodegenerative disorders RE Carson, M Naganawa, T Toyonaga, S Koohsari, Y Yang, MK Chen, ... Journal of Nuclear Medicine 63 (Supplement 1), 60S-67S, 2022 | 35 | 2022 |
| A novel loss function incorporating imaging acquisition physics for PET attenuation map generation using deep learning L Shi, JA Onofrey, EM Revilla, T Toyonaga, D Menard, J Ankrah, ... Medical Image Computing and Computer Assisted Intervention–MICCAI 2019: 22nd …, 2019 | 33 | 2019 |
| Change in 18F-Fluoromisonidazole PET Is an Early Predictor of the Prognosis in the Patients with Recurrent High-Grade Glioma Receiving Bevacizumab Treatment S Yamaguchi, K Hirata, T Toyonaga, K Kobayashi, Y Ishi, H Motegi, ... PLoS One 11 (12), e0167917, 2016 | 29 | 2016 |
| Biodistribution and radiation dosimetry of the novel hypoxia PET probe [18F]DiFA and comparison with [18F]FMISO S Watanabe, T Shiga, K Hirata, K Magota, S Okamoto, T Toyonaga, ... EJNMMI research 9, 1-11, 2019 | 28 | 2019 |
